Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 29 October 2009 as doi:10.1099/mic.0.030304-0
Microbiology (2009), DOI 10.1099/mic.0.030304-0
© 2009 Society for General Microbiology

This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Franke, G. C.
Right arrow Articles by Aepfelbacher, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franke, G. C.
Right arrow Articles by Aepfelbacher, M.
Agricola
Right arrow Articles by Franke, G. C.
Right arrow Articles by Aepfelbacher, M.
Microbiology 0 (2009), mic.0.030304; DOI  10.1099/mic.0.030304-0
© 2009 Society for General Microbiology


Epidemiology, variable genetic organisation and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients

Gefion C. Franke1, Alexandra Böckenholt1, Motoyuki Sugai2, Holger Rohde1 and Martin Aepfelbacher1,3

1 Universitätsklinikum Hamburg-Eppendorf;
2 Hiroshima University Graduate School of Biomedical Sciences

EDIN-B (Epidermal cell Differentiation INhibitor-B; also termed C3Stau) is an exotoxin of S. aureus which ADP-ribosylates and inactivates Rho GTP-binding proteins. The EDIN-B gene (edin-B) and the gene for exfoliative toxin D (etd) make up the central part of a recently described pathogenicity island. Here we evaluated the prevalence and genetic organisation of the edin-B/etd pathogenicity island in invasive S. aureus isolates and characterized edin-B transcription and EDIN-B production using artificial constructs transduced in S. aureus strains RN6390 and -Newman. We found that 8 out of 121 (7 %) S. aureus blood culture isolates harbour edin-B which is organised in three novel variants of the original edin-B/etd pathogenicity island. In the serum of patients infected with edin-B positive S. aureus significant titres of anti-EDIN-B antibodies could be detected. Regulation of edin-B transcription depended on the sarA- but not on the agr regulatory system. Furthermore, retrieval of EDIN-B protein secreted by S. aureus RN6390 required the presence of {alpha}2-macrogobulin to inhibit the activity of extracellular proteases. These data suggest that the EDIN-B toxin is produced during human infection, is part of a highly variable pathogenicity island and can be controlled by the sarA gene regulon and secreted bacterial proteases.

3 E-mail: m.aepfelbacher{at}uke.uni-hamburg.de







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.